RxDoctor Payments Data

David Silkiner, MD

Family Medicine · Simpsonville, SCNPI 1356382733

Payments from drug & device makers

$1,386in general payments, 2019–2025

Across 90 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$206
  • AbbVie$188
  • Pfizer$170
  • Lilly USA, LLC$106
  • Astellas Pharma US Inc$82
  • AstraZeneca$69
  • plus $565 from 19 others

What the payments were for

  • Food & beverage$1,386100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,386 in reported general payments places this provider in the 65th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$164,070
Medicare patients
326
Services billed
2,173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$102,931
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog33$93,408
EliquisApixaban85$74,376
GlyxambiEmpagliflozin/Linagliptin37$39,448
MounjaroTirzepatide26$35,197
Morphine Sulfate ErMorphine Sulfate13$34,731
TradjentaLinagliptin31$28,917
JardianceEmpagliflozin24$22,526
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$19,908
JanuviaSitagliptin Phosphate20$16,759
Jentadueto XrLinagliptin/Metformin Hcl12$15,826
SynthroidLevothyroxine Sodium144$11,040
Janumet XrSitagliptin Phos/Metformin Hcl11$6,174
MyrbetriqMirabegron14$6,080
Esomeprazole Magnesium48$4,902

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimGlyxambi, Tradjenta, Jardiance, Jentadueto Xr$49$106,718104 claims
Novo NordiskOzempic$206$102,93174 claims
PfizerEliquis$170$74,37685 claims
Lilly USA, LLCMounjaro$106$35,19726 claims
MerckJanuvia, Janumet Xr$22$22,93231 claims
GSKTrelegy Ellipta$23$19,90831 claims
AbbVieSynthroid$188$11,040144 claims
Astellas Pharma US IncMyrbetriq$82$6,08014 claims
AstraZenecaPulmicort Flexhaler$69$3,31811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Simpsonville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →